Recently Published Articles
2023 2022 2021 2020 2019 2018 2017 2016
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study. Ritchlin CT, Coates LC, McInnes IB, Mease PJ, Merola JF, Tanaka Y, Asahina A, Gossec L, Gottlieb AB, Warren RB, Ink B, Bajracharya R, Shende V, Coarse J, Landewé RB. Ann Rheum Dis. 2023 Sep 11:ard-2023-224431.
Changing with the times-learning to pivot as an academic allergist. Bingemann TA, Hernandez-Trujillo V. Ann Allergy Asthma Immunol. 2023 Sep;131(3):288-289.
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial. O'O'Halloran JA, Ko ER, Anstrom KJ, Kedar E, McCarthy MW, Panettieri RA Jr, Maillo M, Nunez PS, Lachiewicz AM, Gonzalez C, Smith PB, de Tai SM, Khan A, Lora AJM, Salathe M, Capo G, Gonzalez DR, Patterson TF, Palma C, Ariza H, Lima MP, Blamoun J, Nannini EC, Sprinz E, Mykietiuk A, Alicic R, Rauseo AM, Wolfe CR, Witting B, Wang JP, Parra-Rodriguez L, Der T, Willsey K, Wen J, Silverstein A, O'Brien SM, Al-Khalidi HR, Maldonado MA, Melsheimer R, Ferguson WG, McNulty SE, Zakroysky P, Halabi S, Benjamin DK Jr, Butler S, Atkinson JC, Adam SJ, Chang S, LaVange L, Proschan M, Bozzette SA, Powderly WG; ACTIV-1 IM Study Group Members. JAMA. 2023 Jul 25;330(4):328-339.
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department. Acquisto, Nicole M.; Bodkin, Ryan P.; Vabishchevich, Yulia; Falkowski, Marek, W.; Tuttle; Steven Christopher; Jones, Courtney MC ; Weis, Emily; Bingemann, Theresa A. . Allergy and Asthma Proceedings. Volume 44, Number 4, 1 July 2023, pp. 283-290(8).
2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis. England, BR , Smith, BJ , et. al. Arthritis Rheumatol 2023 May 25.
Reducedangiogenesis and delayed endochondral ossification in CD163-/- mice highlights a role of M2 macrophages during bone fracture repair. Ren Y, Zhang S, Weeks J, Rangel-Moreno J, He B, Xue T, Rainbolt J, Morita Y, Shu Y, Liu Y, Kates SL, Schwarz EM and Xie C Journal of Orthopaedic Research. In press, 2023.
Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control. Swanson RW, Gupta A, Foreman TW, Lu L, Choreno-Parra JA, Mbandi K, Rosa BA, Akter S, Ahmed M, Garcia-Hernandez ML, Singh DK, Esaulova E, Artyomov MN, Gommerman J, Mehra S, Zuniga J, Mitreva M, Scriba TJ, Rangel-Moreno J, Kaushal D and Khader SA. Nature Immunology. 2023 Apr 3.
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies. McGonagle D, McInnes IB, Deodhar A, Schett G, Shawi M, Chakravarty SD, Kollmeier AP, Xu XL, Sheng S, Xu S, Ritchlin CT, Rahman P, Mease PJ. ACR open rheumatology.. 2023 Mar 7; Epub 2023 Mar 07.
Near-Infrared Imaging of Indocyanine Green Identifies Novel Routes of Lymphatic Drainage from Metacarpophalangeal Joints in Healthy Human Hands. Kenney HM, Dieudonne G, Yee S, Maki JH, Wood RW, Schwarz EM, Ritchlin CT, Rahimi H. Lymphatic research and biology.. 2023 Feb 20; Epub 2023 Feb 20.
Food protein-induced enterocolitis syndrome: Healthcare utilization and referral patterns among a pediatric cohort. Pier J, Bingemann T, Badwal J, Rosloff D, Pasha M, Wang H, Lomas JM, Järvinen KM. . 2023 4:1102410. Epub 2023 Feb 10.
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. Ritchlin CT, Deodhar A, Boehncke WH, Soriano ER, Kollmeier AP, Xu XL, Zazzetti F, Shawi M, Jiang Y, Sheng S, Helliwell PS. ACR open rheumatology.. 2023 Feb 10; Epub 2023 Feb 10.
The Need for Required Stock Epinephrine in All Schools: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee. Russell AF, Bingemann TA, Cooke AT, Ponda P, Pistiner M, Jean T, Nanda A, Jobrack J, Hoyt AEW, Young MC. The journal of allergy and clinical immunology. In practice.. 2023 Jan 27; Epub 2023 Jan 27.
Educating the Clinician: Importance of Black Participation in Lupus Clinical Trials. Anandarajah, A. Rheum Advisor. 2023 Jan.
Immune Dysregulation. Long, A, Kleiner, A, Looney, R. J Allergy Clin Immunol. 2023 Jan:151(1):70-80.
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial." Ritchlin CT, Coates LC, Mease PJ, van der Heijde D, Song J, Jiang Y, Shawi M, Kollmeier AP, Rahman P. Trials.. 2023 Jan 10; 24(1):22. Epub 2023 Jan 10.